Jul. 18, 2014
Colombia is a key Latin American market for U.S. agricultural products with export values over $1.5 billion in 2013. The implementation of the U.S.-Colombia Trade Promotion Agreement (CTPA) has increased trade opportunities. U.S. exports in products derived from biotechnology or genetic engineering such as corn, cotton, soybeans, soybean meal, soybean oil, and distillers grains were valued at over $500 million in 2013.
The Colombian legal framework for agricultural biotechnology regulations remains under review. Colombia approved the Cartagena Protocol on Biosafety (CPB) in 2002. In 2005, Decree 4525 was published to implement the CBP and since then several other Ministerial resolutions were published to outline specific requirements and procedures for approving and using GE products in Colombia.
Colombia's biotechnology regulations are regularly reviewed and revised, which provides opportunities to engage GOC regulatory counterparts with outreach activities to facilitate the adoption of science-based regulations. The GOC has created three technical biotechnology committees to analyze environmental, biosafety and food safety impacts of biotech-derived products. The MHSP issued resolution 4254 establishing the requirements for labeling of foods derived from modern biotechnology. The resolution entered into force at the end of June, 2012. In addition to the resolution, the GOC is working on a Technical Annex which supplements the resolution and is expected to be issued in late 2014.
In 2002, GE cotton was approved and was the first biotech plant cultivated on a non-restricted commercial basis in Colombia. GE corn was approved in 2007 and continues to surpass GE cotton adoption with area planted increasing to 75 thousand hectares in 2013. Also, GE Dutch blue carnations continue to be produced under greenhouse conditions for export to Europe as well as GE blue petal roses for exports to Japan.
View More